Multiple use of preservative-free single dose unit dexamethasone 0.1% eye drops is safe within 24 hours

被引:0
|
作者
Fierz, Fabienne C. [1 ,2 ,3 ]
Locher, Silvan [1 ]
Bachmann, Lucas [1 ,4 ]
Baenninger, Philipp B. [1 ,3 ]
Bochmann, Frank [1 ]
Kaufmann, Claude [1 ]
Mitrovic, Irena [5 ]
Rossi, Marco [6 ]
Thiel, Michael A. [1 ]
Howell, Jeremy P. [1 ]
机构
[1] Cantonal Hosp Lucerne, Dept Ophthalmol, Luzern, Switzerland
[2] Univ Hosp Zurich, Dept Ophthalmol, Zurich, Switzerland
[3] Cantonal Hosp Winterthur, Dept Ophthalmol, Winterthur, Switzerland
[4] Medignition AG, Zurich, Switzerland
[5] Cantonal Hosp Lucerne, Med Microbiol, Luzern, Switzerland
[6] Cantonal Hosp Lucerne, Dept Infectiol & Hosp Hyg, Luzern, Switzerland
来源
BMJ OPEN OPHTHALMOLOGY | 2024年 / 9卷 / 01期
关键词
diagnostic tests/investigation; eye lids; ocular surface; microbiology; MICROBIAL-CONTAMINATION; OPHTHALMIC SOLUTIONS; INFECTION; EYEDROPS; FUNGAL; RISK;
D O I
10.1136/bmjophth-2024-001632
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Unpreserved single-dose unit (SDU) eye drops are commonly used to avoid benzalkonium chloride-related toxicity. Although intended for single use, many patients report off-label repeated use of SDUs over a prolonged period. We investigated whether repeated use of dexamethasone 0.1% SDUs in the same patient increases the bacterial contamination rate.Methods We prospectively enrolled patients scheduled for inpatient corneal and glaucoma surgery receiving dexamethasone 0.1% SDU four times per day from the same vial. To assess contamination rates, one drop from the vial was cultured immediately after opening the SDU (t0), 10 hours later after four drop applications (t10) and 24 hours after opening without further drop applications (t24). Conjunctival swabs were taken before and after drop application. Contamination rate was assessed with a standard clinical culturing protocol without introducing a positive control.Results 110 eyes of 109 patients were evaluated. Drops collected immediately after opening the SDU (t0) were contaminated in 9/110 cultures (8.1%). At t10, 13/110 cultures were contaminated (11.8%; p=0.267) and 11/110 at t24 (10.0%; t24 vs t0; p=1.00). In 5 of 21 cases of contaminated drops at t10 and/or t24, the same isolates were cultured from the initial conjunctival swab and the SDU. In three cases, the same bacterial species was found in consecutive samples.Conclusion The contamination rate of the SDU did not increase after multiple use within 24 hours. Contamination from fingertip flora was more likely than from ocular surface flora. Reuse of dexamethasone 0.1% SDU in the same patient within 24 hours appears to be safe.
引用
收藏
页数:7
相关论文
共 14 条
  • [1] The effects of preservative-free dexamethasone 0.1% followed by cyclosporine 0.1% eye drops in the treatment of dry eye disease
    Kamoy, Bjornar
    Storas, Andrea
    Hammer, Hugo
    Magno, Morten
    Chen, Xiangjun
    Khan, Ayyad
    Utheim, Tor
    Fineide, Fredrik
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [2] The effects of topical preservative-free dexamethasone 0.1% and artificial tear drops on dry eye disease parameters
    Steinkjer, Tore
    Chen, Xiangjun
    Khan, Ayyad
    Magno, Morten
    Hammer, Hugo
    Fineide, Fredrik
    Utheim, Tor
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [3] A Stable Preservative-free Fixed Combination (Nepafenac 0.1%-Dexamethasone Phosphate 0.1%) Anti-inflammatory Eye Drops
    Saita, Maria
    Aleo, Danilo
    Spitaleri, Fabiola
    Melilli, Barbara
    Amico, Valentina
    Cro, Melina
    Mangiafico, Sebastiano
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [4] CONTAMINATION RATE AND ECONOMIC EVALUATION FOR REPEATED USE OF MEDICATED PRESERVATIVE-FREE UNIT-DOSE EYE DROPS
    Tahoun, A.
    Zawara, A.
    Nour, El-Din H.
    Osman, A.
    VALUE IN HEALTH, 2023, 26 (06) : S136 - S136
  • [5] Vizilatan® Preservative-free eye drops in multi-dose vials
    不详
    ACTUALITES PHARMACEUTIQUES, 2020, 59 (592): : 11 - 11
  • [6] Bilastine 0.6% once-daily, preservative-free eye drops pharmacokinetics after single and multiple dose administration
    Nieves, Fernandez
    Hernandez, Gonzalo
    Arranz, Paula
    Ochoa, Dolores
    Mejia, Gina
    Roman, Manuel
    Aabad, Francisco
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [7] Long term use of a preservative-free 0.1 % dexamethasone after photorefractive keratectomy
    Russo, P
    Lazzarotto, M
    Favero, A
    Tomasello, M
    Sforzi, C
    Papa, V
    Milazzo, G
    Caporossi, A
    ISOPT: PROCEEDINGS OF THE 5TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2004, : 263 - 266
  • [8] Preservative-Free Topical Anesthetic Unit-Dose Eye Drops for the Management of Postoperative Pain Following Photorefractive Keratectomy
    Mahmoud Abdel-Radi
    Zeiad Eldaly
    Sara Alattar
    Islam Goda
    Ophthalmology and Therapy, 2023, 12 : 3025 - 3038
  • [9] Preservative-Free Topical Anesthetic Unit-Dose Eye Drops for the Management of Postoperative Pain Following Photorefractive Keratectomy
    Abdel-Radi, Mahmoud
    Eldaly, Zeiad
    Alattar, Sara
    Goda, Islam
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (06) : 3025 - 3038
  • [10] Additive Effect of Preservative-free Sodium Hyaluronate 0.1% in Treatment of Dry Eye Syndrome With Diquafosol 3% Eye Drops
    Hwang, Ho Sik
    Sung, Yoon-mi
    Lee, Weon Sun
    Kim, Eun Chul
    CORNEA, 2014, 33 (09) : 935 - 941